SLC2A2 and diabetic kidney disease: Following our finding that the CB1R/mTORC1/SREBP1c signaling pathway regulates GLUT2 transcriptional expression in RPTCs, we next assessed whether a reduction in GLUT2 expression is sufficient to prevent DKD.